tetano
Editor, Senior Moderator
Pediatr Nephrol
. 2022 Nov 30;1-10.
doi: 10.1007/s00467-022-05783-z. Online ahead of print.
Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
Shingo Ishimori[SUP] 1 [/SUP], Tomoko Horinouchi[SUP] 2 [/SUP], Junya Fujimura[SUP] 3 [/SUP], Tomohiko Yamamura[SUP] 2 [/SUP], Natsuki Matsunoshita[SUP] 4 [/SUP], Naohiro Kamiyoshi[SUP] 5 [/SUP], Mai Sato[SUP] 6 [/SUP], Masao Ogura[SUP] 6 [/SUP], Koichi Kamei[SUP] 6 [/SUP], Kenji Ishikura[SUP] 7 [/SUP], Kazumoto Iijima[SUP] 8 9 [/SUP], Kandai Nozu[SUP] 2 [/SUP]
Affiliations
Abstract
Background: Prospective research of children receiving heterogeneous vaccines has shown that immunization is not associated with pediatric idiopathic nephrotic syndrome (NS) relapses. However, prospective data concentrating only on influenza (flu) virus vaccines are not available.
Methods: This multicenter prospective study was conducted in children with NS who received inactivated flu vaccines from June 2017 to July 2018. The day of flu vaccination was defined as day 0, and the period between prevaccination and postvaccination days was defined as - X to + Y (period from day - 180 to 0 as the precontrolled period). The primary outcome was the NS relapse rate from day 0 to + 30 as a direct association with vaccination compared with those in the precontrolled period. Exacerbation was defined as children experiencing more NS relapses after vaccination compared with those in the precontrolled period, or children starting any new immunosuppressants due to NS relapse after vaccination.
Results: Sixty-three children were included. Relapse rates were not significantly different between the precontrolled period and 0 to + 30 periods (0.38 vs. 0.19 times/person-year, p = 0.95). Although the exacerbation rate during the 0 to + 180 period in children without NS relapse in the precontrolled period was very low (4/54 [7.4 %]), children with at least one NS relapse in the precontrolled period showed a remarkable increase in the rate (4/9 [44.4%]; p = 0.01).
Conclusions: Flu vaccination did not significantly precipitate the direct relapse of NS in children. However, it might increase the disease activity in children with at least one NS relapse within a half year before vaccination. A higher resolution version of the Graphical abstract is available as Supplementary information.
Keywords: Adverse event; Exacerbation; Idiopathic nephrotic syndrome; Influenza virus vaccination; Relapse.
. 2022 Nov 30;1-10.
doi: 10.1007/s00467-022-05783-z. Online ahead of print.
Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
Shingo Ishimori[SUP] 1 [/SUP], Tomoko Horinouchi[SUP] 2 [/SUP], Junya Fujimura[SUP] 3 [/SUP], Tomohiko Yamamura[SUP] 2 [/SUP], Natsuki Matsunoshita[SUP] 4 [/SUP], Naohiro Kamiyoshi[SUP] 5 [/SUP], Mai Sato[SUP] 6 [/SUP], Masao Ogura[SUP] 6 [/SUP], Koichi Kamei[SUP] 6 [/SUP], Kenji Ishikura[SUP] 7 [/SUP], Kazumoto Iijima[SUP] 8 9 [/SUP], Kandai Nozu[SUP] 2 [/SUP]
Affiliations
- PMID: 36449102
- PMCID: PMC9709736
- DOI: 10.1007/s00467-022-05783-z
Abstract
Background: Prospective research of children receiving heterogeneous vaccines has shown that immunization is not associated with pediatric idiopathic nephrotic syndrome (NS) relapses. However, prospective data concentrating only on influenza (flu) virus vaccines are not available.
Methods: This multicenter prospective study was conducted in children with NS who received inactivated flu vaccines from June 2017 to July 2018. The day of flu vaccination was defined as day 0, and the period between prevaccination and postvaccination days was defined as - X to + Y (period from day - 180 to 0 as the precontrolled period). The primary outcome was the NS relapse rate from day 0 to + 30 as a direct association with vaccination compared with those in the precontrolled period. Exacerbation was defined as children experiencing more NS relapses after vaccination compared with those in the precontrolled period, or children starting any new immunosuppressants due to NS relapse after vaccination.
Results: Sixty-three children were included. Relapse rates were not significantly different between the precontrolled period and 0 to + 30 periods (0.38 vs. 0.19 times/person-year, p = 0.95). Although the exacerbation rate during the 0 to + 180 period in children without NS relapse in the precontrolled period was very low (4/54 [7.4 %]), children with at least one NS relapse in the precontrolled period showed a remarkable increase in the rate (4/9 [44.4%]; p = 0.01).
Conclusions: Flu vaccination did not significantly precipitate the direct relapse of NS in children. However, it might increase the disease activity in children with at least one NS relapse within a half year before vaccination. A higher resolution version of the Graphical abstract is available as Supplementary information.
Keywords: Adverse event; Exacerbation; Idiopathic nephrotic syndrome; Influenza virus vaccination; Relapse.